PUBLISHER: The Business Research Company | PRODUCT CODE: 1947071
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947071
Respiratory disposables are used to connect respiratory devices, such as ventilators, nebulizers, and oxygen therapy devices, with patients. They help maintain hygiene and prevent cross-contamination during procedures that involve ventilation or oxygen delivery.
The primary categories of respiratory disposables include masks, tubes, inhalers, and other related items. Masks are typically made of cloth or similar materials and are a form of personal protective equipment with medical applications. They are utilized in the treatment of various respiratory conditions, including asthma, chronic obstructive pulmonary disorder (COPD), tuberculosis, lung cancer, and other chronic respiratory diseases. These disposables find applications across different patient groups, including adults, pediatric patients, and neonates. End-users for respiratory disposables encompass hospitals, clinics, ambulatory care centers, and other healthcare facilities.
Tariffs are influencing the respiratory disposables market by increasing costs of imported polymers, medical-grade plastics, filters, and packaging materials used in masks, tubes, inhalers, and ventilator circuits. Hospitals and clinics in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces higher costs for export-oriented production. These tariffs are increasing per-procedure costs and procurement expenses. At the same time, they are encouraging local manufacturing, regional sourcing of raw materials, and innovation in cost-effective and biodegradable respiratory disposable products.
The respiratory disposables market research report is one of a series of new reports from The Business Research Company that provides respiratory disposables market statistics, including respiratory disposables industry global market size, regional shares, competitors with a respiratory disposables market share, detailed respiratory disposables market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disposables industry. This respiratory disposables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory disposables market size has grown rapidly in recent years. It will grow from $1.13 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to increasing hospital-acquired infection concerns, expansion of intensive care unit capacity, rising use of ventilators and oxygen therapy, increased surgical procedures requiring respiratory support, availability of low-cost disposable materials.
The respiratory disposables market size is expected to see rapid growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to increasing demand for eco-friendly respiratory disposables, rising respiratory disease incidence, expansion of homecare respiratory treatments, growing focus on patient safety compliance, increasing healthcare spending on consumables. Major trends in the forecast period include increasing demand for single-use respiratory interfaces, growing focus on infection control products, rising adoption of disposable ventilator accessories, expansion of pediatric and neonatal respiratory consumables, enhanced emphasis on material safety and comfort.
The growing demand for telehealth is anticipated to drive the expansion of the respiratory disposables market in the coming years. Telehealth involves the use of telecommunications technologies, including videoconferencing, phone calls, and secure messaging, to deliver healthcare services remotely. Telehealth enables patients to access remote consultations with healthcare providers for respiratory conditions. During these virtual visits, healthcare professionals can evaluate patients' symptoms and recommend suitable treatments, including the use of respiratory disposables such as masks, nebulizers, or inhalers. For example, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, telehealth utilization increased nationally by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing adoption of telehealth is contributing to the growth of the respiratory disposables market.
Major companies operating in the respiratory disposables market are continuing to focus on innovations that enhance comfort and breathability, such as upgrading exhalation valves in surgical respirators to lower exhalation resistance. Advanced exhalation valves are specialized breathing-assist components designed to efficiently release exhaled air from respiratory devices while minimizing heat and moisture buildup and reducing breathing resistance to improve user comfort. For example, in June 2023, 3M, a US-based safety equipment company, introduced an updated version of its Aura N95 particulate respirator (model 9211+, N95) featuring an enhanced 3M Cool Flow Comfort Valve. This valve opens 44% more easily and permits 70% greater airflow compared with the previous design. The enhancement supports extended wear by decreasing heat and moisture accumulation, making the respirator more comfortable during prolonged use.
In March 2024, Medline Industries LP, a US-based healthcare company, acquired the manufacturing rights of AG Cuffill from Hospitech Respiration Ltd. for an undisclosed amount. Through this acquisition, Medline strengthened its respiratory care portfolio by adding an innovative device that simplifies and enhances the accuracy of airway cuff pressure management, supporting improved patient care and expanding its market presence. Hospitech Respiration Ltd. is an Israel-based medical equipment manufacturing company that specializes in airway management solutions and respiratory disposable devices.
Major companies operating in the respiratory disposables market are Fisher & Paykel Appliances Holdings Ltd., Becton Dickinson Company, Ambu A/S, Smiths Medical Inc., Armstrong Medical, Teleflex Incorporated, Philips Respironics, Besmed, ResMed, Dynarex Corporation, Drive Medical, Cardinal Health Inc., Drger Medical, Hamilton Medical, Mercury Medical, SunMed LLC, Ningbo Greetmed Medical Instruments Co.Ltd., Hangzhou Jinlin Medical Appliances Co. Ltd., Hangzhou Tappa Medical Technology Co. Ltd., Weihai Strong Medical Sci-Tech Co.Ltd., Vyaire MedicalInc., Viomedex Ltd., Flexicare Medical Ltd., ICU Medical Inc., GF Health Products Inc., Medline Industries Inc., Westmed Inc., Intersurgical Ltd., Salter Labs Inc., AirLife, Medtronic plc, McKesson Corporation, Owens & Minor Inc., Henry Schein Inc., 3M Company, Johnson & Johnson, Baxter International Inc.
Asia-Pacific was the largest region in the global respiratory disposables and equipment market in 2025. Western Europe was the second-largest region in the respiratory disposables market. The regions covered in the respiratory disposables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the respiratory disposables market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The respiratory disposables market consists of sales of instruments such as disposable resuscitators, disposable masks, nasal cannulas, tracheostomy tubes, and other consumables and accessories. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Disposables Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses respiratory disposables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory disposables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory disposables market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.